Replies to post #2403 on Repro Med Systems Inc (REPR)

[blue_skies]

Xembiy is only been approved in U.S. Other markets likely to follow. In a razor/razor blade model the razor blades for RMS are needle sets and tubing. These high profit items will grow exponentially through 2020 with a major impact on the company bottom line.

Question? Will RMS be able to meet demand? In the Q3 financials look at the inventory numbers compared to previous quarters.